Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Endocrinology 4: Hormone Signaling in Prostate and Other Cancers

Progesterone regulation of hTERT transcription in human endometrial cancer cells.

Victoria L. Bae-Jump, Chunxiao Zhou, Paola A. Gehrig and John F. Boggess
Victoria L. Bae-Jump
University of North Carolina, Chapel Hill, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chunxiao Zhou
University of North Carolina, Chapel Hill, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola A. Gehrig
University of North Carolina, Chapel Hill, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John F. Boggess
University of North Carolina, Chapel Hill, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 2006
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 47, 2006

Abstract

5352

Objectives: In the normal endometrium, progesterone antagonizes the actions of estrogen and inhibits estrogen-induced cellular proliferation. Consequently, progestins have had some therapeutic benefit in the treatment of endometrial cancer. Telomerase activity is dynamic throughout the menstrual cycle and is highest during the proliferative phase under the influence of estrogen and then falls during the secretory phase under the influence of progesterone. Despite this observation, little is known regarding the role of progesterone in the control of telomerase expression. Thus, our goal was to determine progesterone’s role in regulation of telomerase activity in progesterone receptor (PR)-positive endometrial cancer cell lines. Mehods: In our lab, Ishikawa and ECC-1 cells have been previously shown to be estrogen receptor (ER) and PR-positive, and HEC-1B and RL 95-2 cells to be ER and PR-negative. Telomerase activity was assayed using a PCR-based telomeric repeat amplification protocol (TRAP) after cells were exposed to estradiol (E2), medroxyprogesterone acetate (MPA) or both. hTERT mRNA expression was assessed by real-time RT-PCR. To determine whether progesterone regulates transcripton of the hTERT gene, transient expression assays using luciferase reporter plasmids containing varying lengths of the 5’ promoter region of the hTERT gene were performed. Results: Among the PR-positive endometrial cancer cell lines, E2 (10−5 - 10−7 M) increased telomerase activity and hTERT mRNA expression in a dose-dependent manner. In contrast, MPA (10−6 M) inhibited E2 induced telomerase activity in the PR-positive endometrial cancer cell lines by 24 hours. This effect was not seen in the PR-negative endometrial cancer cell lines. hTERT mRNA levels were decreased parallel to suppression of telomerase activity. Luciferase assays demonstrated that exposure to MPA inhibited E2-induced activation of the hTERT promoter which contains two putative estrogen response elements (EREs) but no progesterone response elements (PREs). Conclusions: We provide evidence that progesterone suppresses estrogen-induced hTERT mRNA expression in PR-positive endometrial cancer cell lines. Downregulation of the PR and reactivation of telomerase activity are thought to occur in advanced stages of endometrial cancer; and thus, may be related. Further work focused on the interaction between progesterone, estrogen and telomerase may provide insight into endometrial carcinogenesis as well as the underlying molecular mechanisms of progestins as a targeted therapy for this estrogen-dependent tumor.

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 66 (8 Supplement)
April 2006
Volume 66, Issue 8 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Progesterone regulation of hTERT transcription in human endometrial cancer cells.
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Progesterone regulation of hTERT transcription in human endometrial cancer cells.
Victoria L. Bae-Jump, Chunxiao Zhou, Paola A. Gehrig and John F. Boggess
Cancer Res April 15 2006 (66) (8 Supplement) 1255;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Progesterone regulation of hTERT transcription in human endometrial cancer cells.
Victoria L. Bae-Jump, Chunxiao Zhou, Paola A. Gehrig and John F. Boggess
Cancer Res April 15 2006 (66) (8 Supplement) 1255;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • The effects of novel anti-androgens on androgen receptor action and expression.
  • Inhibition of the prolyl-isomerase PIN-1 enhances the cyto-differentiating activity of retinoids in myeloid leukemia cells.
  • Prostate cancer associated androgen receptor mutation promotes cell growth adn abrogates P53 mediated apoptosis.
Show more Endocrinology 4: Hormone Signaling in Prostate and Other Cancers
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement